Shares of CRH Medical Corp (NYSEARCA:CRHM) have received an average recommendation of “Buy” from the seven ratings firms that are currently covering the company, Marketbeat reports. Two analysts have rated the stock with a hold rating and five have issued a buy rating on the company. The average 12-month price objective among analysts that have issued a report on the stock in the last year is $7.50.

Several research analysts have recently commented on CRHM shares. CIBC downgraded CRH Medical Corp from a “sector outperform” rating to a “sector perform” rating in a research note on Monday, July 17th. TD Securities downgraded CRH Medical Corp from a “buy” rating to a “hold” rating in a research note on Tuesday, July 18th. Scotiabank downgraded CRH Medical Corp from an “outperform” rating to a “sector perform” rating in a research note on Friday, July 14th. Royal Bank Of Canada upgraded CRH Medical Corp from a “sector perform” rating to an “outperform” rating in a research note on Friday, July 21st. Finally, Canaccord Genuity reiterated a “buy” rating and set a $8.00 target price on shares of CRH Medical Corp in a research note on Monday, July 17th.

COPYRIGHT VIOLATION WARNING: This article was first posted by American Banking News and is owned by of American Banking News. If you are accessing this article on another publication, it was illegally stolen and reposted in violation of U.S. and international trademark and copyright laws. The correct version of this article can be viewed at https://www.americanbankingnews.com/2017/10/22/crh-medical-corp-crhm-receives-consensus-rating-of-buy-from-analysts.html.

A number of large investors have recently added to or reduced their stakes in the stock. Mawer Investment Management Ltd. lifted its holdings in CRH Medical Corp by 24.2% during the 2nd quarter. Mawer Investment Management Ltd. now owns 4,742,491 shares of the company’s stock worth $26,999,000 after purchasing an additional 924,540 shares during the last quarter. Pembroke Management LTD lifted its holdings in CRH Medical Corp by 48.4% during the 2nd quarter. Pembroke Management LTD now owns 1,647,800 shares of the company’s stock worth $12,160,000 after purchasing an additional 537,200 shares during the last quarter. Stifel Financial Corp lifted its holdings in CRH Medical Corp by 16.4% during the 2nd quarter. Stifel Financial Corp now owns 1,546,154 shares of the company’s stock worth $8,814,000 after purchasing an additional 217,672 shares during the last quarter. Fiera Capital Corp lifted its holdings in CRH Medical Corp by 39.2% during the 2nd quarter. Fiera Capital Corp now owns 1,451,798 shares of the company’s stock worth $8,247,000 after purchasing an additional 408,959 shares during the last quarter. Finally, Morgan Stanley lifted its holdings in CRH Medical Corp by 102.7% during the 1st quarter. Morgan Stanley now owns 1,288,285 shares of the company’s stock worth $10,564,000 after purchasing an additional 652,737 shares during the last quarter.

Shares of CRH Medical Corp (NYSEARCA:CRHM) opened at 2.35 on Friday. CRH Medical Corp has a 12 month low of $2.15 and a 12 month high of $9.25. The firm’s 50-day moving average price is $2.50 and its 200-day moving average price is $4.51.

About CRH Medical Corp

CRH Medical Corporation is a Canada-based healthcare products and services company. The Company focused on providing physicians with services and products for the treatment of gastrointestinal diseases. The Company also provides anesthesiology services to gastroenterologists in the United States through its subsidiaries.

Analyst Recommendations for CRH Medical Corp (NYSEARCA:CRHM)

Receive News & Ratings for CRH Medical Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CRH Medical Corp and related companies with MarketBeat.com's FREE daily email newsletter.